| Shelly Ann House, MSN, FNP | |
|
18640 E 38th Ter S, Independence, MO 64057-2304 | |
| (816) 229-1191 | |
| (816) 229-1198 |
| Full Name | Shelly Ann House |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Adult Medicine |
| Location | 18640 E 38th Ter S, Independence, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699472068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 2023001571 (Missouri) | Primary |
| 207QA0505X | Family Medicine - Adult Medicine | 5381916012 (Kansas) | Secondary |
| Entity Name | Signify Health Medical Associates Of Kansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780261701 PECOS PAC ID: 8628487998 Enrollment ID: O20210518000551 |
News Archive
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.
Do you cough without covering your mouth while standing in the lunch line? Or sneeze loudly into the air when squeezed onto the morning bus? Nearly all Americans (96 percent) have seen you do things like this - and a shocking three quarters (77 percent) say they are guilty themselves.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelly Ann House, MSN, FNP 7590 N Everton Ave, Kansas City, MO 64152-4685 Ph: (573) 280-4905 | Shelly Ann House, MSN, FNP 18640 E 38th Ter S, Independence, MO 64057-2304 Ph: (816) 229-1191 |
News Archive
An agency within the U.S. Department of Health and Human Services that maintains a discipline and medical-malpractice database reopened it for public access yesterday, two months after the agency had first taken the database offline.
Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.
Biovest International, Inc. (Other OTC:BVTI) today announced at the Active Immunotherapeutics Forum in Barcelona, Spain, that the Company is targeting mantle cell lymphoma, in addition to follicular lymphoma, as a next indication for its personalized cancer vaccine, BiovaxID. At the conference, the Company reviewed positive data from an open label Phase II mantle cell lymphoma clinical trial and reported plans to meet with the FDA later this year to discuss a pathway to seek regulatory approval for this hematological indication for which there is no current consensus standard-of-care.
Do you cough without covering your mouth while standing in the lunch line? Or sneeze loudly into the air when squeezed onto the morning bus? Nearly all Americans (96 percent) have seen you do things like this - and a shocking three quarters (77 percent) say they are guilty themselves.
› Verified 5 days ago
Dr. Michael G Wells, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11605 E 23rd St S, Independence, MO 64050 Phone: 816-579-6891 | |
Dr. Lewis Rosenblatt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4621 S Shrank Dr, Suite B, Independence, MO 64055 Phone: 816-229-3200 Fax: 816-503-8325 | |
Katherine Field, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-312-4380 | |
Ho Lau, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 19600 E 39th St S, Independence, MO 64057 Phone: 913-222-9779 Fax: 816-312-4380 | |
Dr. Janet Eileen Morgan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1520 E 23rd St, Suite I, Independence, MO 64055 Phone: 816-836-4740 Fax: 816-836-4745 | |
Jennifer J Patterson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4721 S Cliff Ave, Suite 200, Independence, MO 64055 Phone: 816-503-3700 Fax: 816-503-3704 | |
Katherine Suzanne Lee, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12400 E Us Highway 40, Independence, MO 64055 Phone: 816-890-9507 Fax: 816-890-9516 |